{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:51:02Z","timestamp":1794714662320,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-05839-8","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T10:15:00Z","timestamp":1768299300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hospital-adapted inhaled phage therapy for ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae: a comparative pilot study"],"prefix":"10.1186","volume":"30","author":[{"given":"Roman","family":"Gorodnichev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor","family":"Shitikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Gurkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Kochetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Kuzovlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Bespiatykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Malakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Zaychikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia","family":"Krivulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kornienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bespyatykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Khromykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Goloshchapov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Uskevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Yakovlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Grechko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor","family":"Zurabov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"5839_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399:629\u201355.","journal-title":"The Lancet"},{"key":"5839_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2478\/jccm-2025-0020","volume":"11","author":"P Piscitelli","year":"2025","unstructured":"Piscitelli P, Costigliola V, Azamfirei L. The challenge of antimicrobial resistance in intensive care setting. J Crit Care Med. 2025;11:109\u201311.","journal-title":"J Crit Care Med"},{"key":"5839_CR3","volume-title":"Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"WHO Bacterial Priority Pathogens List","year":"2024","unstructured":"WHO Bacterial Priority Pathogens List. Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. London: World Health Organization; 2024."},{"key":"5839_CR4","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1093\/cid\/ciy692","volume":"67","author":"J Xie","year":"2018","unstructured":"Xie J, Yang Y, Huang Y, et al. The current epidemiological landscape of ventilator-associated pneumonia in the intensive care unit: a multicenter prospective observational study in China. Clin Infect Dis. 2018;67:S153\u201361.","journal-title":"Clin Infect Dis"},{"key":"5839_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13040290","volume":"13","author":"P Mergulh\u00e3o","year":"2024","unstructured":"Mergulh\u00e3o P, Pereira JG, Fernandes AV, et al. Epidemiology and burden of ventilator-associated pneumonia among adult intensive care unit patients: a Portuguese, multicenter, retrospective study (eVAP-PT study). Antibiotics. 2024;13:290.","journal-title":"Antibiotics"},{"key":"5839_CR6","volume":"15","author":"U \u00d6nal","year":"2023","unstructured":"\u00d6nal U, T\u00fczemen \u00dc, Kaya PK, et al. OXA-48 dominance meets ceftazidime-avibactam: a battle against life-threatening carbapenem-resistant klebsiella pneumoniae infections in the intensive care unit. Cureus. 2023;15:e46780.","journal-title":"Cureus"},{"key":"5839_CR7","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001895","volume":"73","author":"CF Uchechukwu","year":"2024","unstructured":"Uchechukwu CF, Shonekan A. Current status of clinical trials for phage therapy. J Med Microbiol. 2024;73:001895.","journal-title":"J Med Microbiol"},{"key":"5839_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","volume":"21","author":"L Leitner","year":"2021","unstructured":"Leitner L, Ujmajuridze A, Chanishvili N, et al. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. Lancet Infect Dis. 2021;21:427\u201336.","journal-title":"Lancet Infect Dis"},{"key":"5839_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5604\/01.3001.0015.0084","volume":"75","author":"KG Dobretsov","year":"2021","unstructured":"Dobretsov KG, Kolenchukova O, Sipkin A, Bellussi LM, Ciprandi G, Passali D. A randomized, double-blind, placebo-controlled study to investigate the use of bacteriophages in patients with chronic rhinosinusitis with nasal polyps. Otolaryngol Pol. 2021;75:33\u20137.","journal-title":"Otolaryngol Pol"},{"key":"5839_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60598-4","volume":"16","author":"I Weiner","year":"2025","unstructured":"Weiner I, Kahan-Hanum M, Buchstab N, et al. Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial. Nat Commun. 2025;16:5579.","journal-title":"Nat Commun"},{"key":"5839_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/20499361241307841","volume":"12","author":"P Sarkodie-Addo","year":"2025","unstructured":"Sarkodie-Addo P, Osman A-H, Aglomasa BC, Donkor ES. Phage therapy in the management of respiratory and pulmonary infections: a systematic review. Therap Adv Infect Dis. 2025;12:20499361241307841.","journal-title":"Therap Adv Infect Dis"},{"key":"5839_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0121-2022","author":"G Mitropoulou","year":"2022","unstructured":"Mitropoulou G, Koutsokera A, Csajka C, et al. Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations. Eur Respir Rev. 2022. https:\/\/doi.org\/10.1183\/16000617.0121-2022.","journal-title":"Eur Respir Rev"},{"key":"5839_CR13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"J-P Pirnay","year":"2024","unstructured":"Pirnay J-P, Djebara S, Steurs G, et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat Microbiol. 2024;9:1434\u201353.","journal-title":"Nat Microbiol"},{"key":"5839_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s42770-023-01036-9","volume":"54","author":"JPR Furlan","year":"2023","unstructured":"Furlan JPR, Stehling EG. Predicting tigecycline susceptibility in multidrug-resistant Klebsiella species and Escherichia coli strains of environmental origin. Braz J Microbiol. 2023;54:1915\u201321.","journal-title":"Braz J Microbiol"},{"key":"5839_CR15","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1128\/JCM.01924-13","volume":"51","author":"S Brisse","year":"2013","unstructured":"Brisse S, Passet V, Haugaard AB, et al. Wzi gene sequencing, a rapid method for determination of capsulartype for klebsiella strains. J Clin Microbiol. 2013;51:4073\u20138.","journal-title":"J Clin Microbiol"},{"key":"5839_CR16","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1128\/JCM.43.8.4178-4182.2005","volume":"43","author":"L Diancourt","year":"2005","unstructured":"Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43:4178\u201382.","journal-title":"J Clin Microbiol"},{"key":"5839_CR17","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.3390\/ijms24044038","volume":"24","author":"RB Gorodnichev","year":"2023","unstructured":"Gorodnichev RB, Kornienko MA, Malakhova MV, et al. Isolation and characterization of the first zobellviridae family bacteriophage infecting Klebsiella pneumoniae. Int J Mol Sci. 2023;24:4038.","journal-title":"Int J Mol Sci"},{"key":"5839_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-60327-164-6_14","volume":"501","author":"E Kutter","year":"2009","unstructured":"Kutter E. Phage host range and efficiency of plating. Methods Mol Biol. 2009;501:141\u20139.","journal-title":"Methods Mol Biol"},{"key":"5839_CR19","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61\u2013111.","journal-title":"Clin Infect Dis"},{"key":"5839_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00134-003-2018-2","volume":"30","author":"CAM Schurink","year":"2004","unstructured":"Schurink CAM, Nieuwenhoven CAV, Jacobs JA, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med. 2004;30:217\u201324.","journal-title":"Intensive Care Med"},{"key":"5839_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1378\/chest.07-0617","volume":"132","author":"TW Rice","year":"2007","unstructured":"Rice TW, Wheeler AP, Bernard GR, et al. Comparison of the SpO2\/FIO2 ratio and the PaO2\/FIO2 ratio in patients with acute lung injury or ARDS. Chest. 2007;132:410\u20137.","journal-title":"Chest"},{"key":"5839_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jcrc.2014.01.010","volume":"29","author":"PSL da Silva","year":"2014","unstructured":"da Silva PSL, de Aguiar VE, de Carvalho WB, Machado Fonseca MC. Value of clinical pulmonary infection score in critically ill children as a surrogate for diagnosis of ventilator-associated pneumonia. J Crit Care. 2014;29:545\u201350.","journal-title":"J Crit Care"},{"key":"5839_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/v14122614","author":"FM Zurabov","year":"2022","unstructured":"Zurabov FM, Chernevskaya EA, Beloborodova NV, et al. Bacteriophage cocktails in the post-COVID rehabilitation. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14122614.","journal-title":"Viruses"},{"key":"5839_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.15360\/1813-9779-2021-6-4-14","volume":"17","author":"NV Beloborodova","year":"2021","unstructured":"Beloborodova NV, Grechko AV, Gurkova MM, et al. Adaptive phage therapy in the treatment of patients with recurrent pneumonia (Pilot study). Gen Reanimatol. 2021;17:4\u201314.","journal-title":"Gen Reanimatol"},{"key":"5839_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/v13010060","author":"D Lebeaux","year":"2021","unstructured":"Lebeaux D, Merabishvili M, Caudron E, et al. A case of phage therapy against pandrug-resistant achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13010060.","journal-title":"Viruses"},{"key":"5839_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v15020588","volume":"15","author":"C Willy","year":"2023","unstructured":"Willy C, Bugert JJ, Classen AY, et al. Phage therapy in germany\u2014update 2023. Viruses. 2023;15:1\u201323.","journal-title":"Viruses"},{"key":"5839_CR27","doi-asserted-by":"publisher","first-page":"S433","DOI":"10.1093\/cid\/ciad483","volume":"77","author":"A G\u00f3rski","year":"2023","unstructured":"G\u00f3rski A, Mi\u0119dzybrodzki R, Jo\u0144czyk-Matysiak E, Kniotek M, Letkiewicz S. Therapeutic phages as modulators of the immune response: practical implications. Clin Infect Dis. 2023;77:S433-9.","journal-title":"Clin Infect Dis"},{"key":"5839_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19922-x","volume":"12","author":"T Suda","year":"2022","unstructured":"Suda T, Hanawa T, Tanaka M, et al. Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection. Sci Rep. 2022;12:15656.","journal-title":"Sci Rep"},{"key":"5839_CR29","doi-asserted-by":"publisher","first-page":"e00824-21","DOI":"10.1128\/AAC.00824-21","volume":"66","author":"S Rao","year":"2022","unstructured":"Rao S, Betancourt-Garcia M, Kare-Opaneye YO, et al. Critically ill patient with multidrug-resistant acinetobacter baumannii respiratory infection successfully treated with intravenous and nebulized bacteriophage therapy. Antimicrob Agents Chemother. 2022;66:e00824-21.","journal-title":"Antimicrob Agents Chemother"},{"key":"5839_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2021.631585","volume":"11","author":"X Tan","year":"2021","unstructured":"Tan X, Chen H, Zhang M, et al. Clinical experience of personalized phage therapy against carbapenem-resistant Acinetobacter baumannii lung infection in a patient with chronic obstructive pulmonary disease. Front Cell Infect Microbiol. 2021;11:1\u20137.","journal-title":"Front Cell Infect Microbiol"},{"key":"5839_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciac453","volume":"76","author":"RM Dedrick","year":"2023","unstructured":"Dedrick RM, Smith BE, Cristinziano M, et al. Phage therapy of mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease. Clin Infect Dis. 2023;76:103\u201312.","journal-title":"Clin Infect Dis"},{"key":"5839_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14020114","volume":"14","author":"DI Munteanu","year":"2025","unstructured":"Munteanu DI, Dunn J, Apjok G, et al. Phage therapy for orthopaedic infections: the first three cases from the United Kingdom. Antibiotics. 2025;14:114.","journal-title":"Antibiotics"},{"key":"5839_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020186","volume":"15","author":"S W\u00fcrstle","year":"2022","unstructured":"W\u00fcrstle S, Stender J, Hammerl JA, et al. Practical assessment of an interdisciplinary bacteriophage delivery pipeline for personalized therapy of Gram-negative bacterial infections. Pharmaceuticals (Basel). 2022;15:186.","journal-title":"Pharmaceuticals (Basel)"},{"key":"5839_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47192-w","volume":"15","author":"JD Berkson","year":"2024","unstructured":"Berkson JD, Wate CE, Allen GB, et al. Phage-specific immunity impairs efficacy of bacteriophage targeting vancomycin resistant Enterococcus in a murine model. Nat Commun. 2024;15:2993.","journal-title":"Nat Commun"},{"key":"5839_CR35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/EBC20240015","volume":"68","author":"MJ Cheetham","year":"2024","unstructured":"Cheetham MJ, Huo Y, Stroyakovski M, et al. Specificity and diversity of Klebsiella pneumoniae phage-encoded capsule depolymerases. Essays Biochem. 2024;68:661\u201377.","journal-title":"Essays Biochem"},{"key":"5839_CR36","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00254-24","volume":"12","author":"C Ferriol-Gonz\u00e1lez","year":"2024","unstructured":"Ferriol-Gonz\u00e1lez C, Concha-Eloko R, Bernab\u00e9u-Gimeno M, et al. Targeted phage hunting to specific Klebsiella pneumoniae clinical isolates is an efficient antibiotic resistance and infection control strategy. Microbiol Spectr. 2024;12:e0025424.","journal-title":"Microbiol Spectr"},{"key":"5839_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00272-24","volume":"98","author":"L Kelly","year":"2024","unstructured":"Kelly L, Jameson E. Bacteriophage cocktail shows no toxicity and improves the survival of Galleria mellonella infected with Klebsiella spp. J Virol. 2024;98:e0027224.","journal-title":"J Virol"},{"key":"5839_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/124021","volume":"2013","author":"C Lelubre","year":"2013","unstructured":"Lelubre C, Anselin S, Zouaoui Boudjeltia K, Biston P, Piagnerelli M. Interpretation of c-reactive protein concentrations in critically ill patients. Biomed Res Int. 2013;2013:124021.","journal-title":"Biomed Res Int"},{"key":"5839_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00721-4","volume":"10","author":"A Gaudet","year":"2020","unstructured":"Gaudet A, Martin-Loeches I, Povoa P, et al. Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia. Ann Intensive Care. 2020;10:101.","journal-title":"Ann Intensive Care"},{"key":"5839_CR40","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0029-2024","volume":"33","author":"A Vaezi","year":"2024","unstructured":"Vaezi A, Healy T, Ebrahimi G, Rezvankhah S, Hashemi Shahraki A, Mirsaeidi M. Phage therapy: breathing new tactics into lower respiratory tract infection treatments. Eur Respir Rev. 2024;33:240029.","journal-title":"Eur Respir Rev"},{"key":"5839_CR41","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/cid\/ciad335","volume":"77","author":"SI Green","year":"2023","unstructured":"Green SI, Clark JR, Santos HH, et al. A retrospective, observational study of 12 cases of expanded-access customized phage therapy: production, characteristics, and clinical outcomes. Clin Infect Dis. 2023;77:1079\u201391.","journal-title":"Clin Infect Dis"},{"key":"5839_CR42","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan BK, Stanley GL, Kortright KE, et al. Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat Med. 2025;31:1494\u2013501.","journal-title":"Nat Med"},{"key":"5839_CR43","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","volume":"185","author":"S Federici","year":"2022","unstructured":"Federici S, Kredo-Russo S, Vald\u00e9s-Mas R, et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell. 2022;185:2879-2898.e24.","journal-title":"Cell"},{"key":"5839_CR44","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/antibiotics10060627","volume":"10","author":"S Letkiewicz","year":"2021","unstructured":"Letkiewicz S, \u0141usiak-Szelachowska M, Miedzybrodzki R, Zaczek M, Weber-Dabrowska B, G\u00f3rski A. Low immunogenicity of intravesical phage therapy for urogenitary tract infections. Antibiotics (Basel). 2021;10:627.","journal-title":"Antibiotics (Basel)"},{"key":"5839_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa389","volume":"7","author":"S Aslam","year":"2020","unstructured":"Aslam S, Lampley E, Wooten D, et al. Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infect Dis. 2020;7:ofaa389.","journal-title":"Open Forum Infect Dis"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-05839-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:02:52Z","timestamp":1770652972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-05839-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5839"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-05839-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local Ethics Committee of the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology (protocol No. 4\/21\/5, September 29, 2021). Written informed consent was obtained from the legal representatives of all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}